Scarica l'app Stockscreener
30.07
0.70%
0.21
Dopo l'orario di chiusura:
30.07
Precedente Chiudi:
$29.86
Aprire:
$29.86
Volume 24 ore:
445.41K
Relative Volume:
1.54
Capitalizzazione di mercato:
$966.20M
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
25.27
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
-5.38%
1M Prestazione:
-0.76%
6M Prestazione:
-6.38%
1 anno Prestazione:
-22.08%
Intervallo 1D:
$29.19
$30.92
Intervallo di 1 settimana:
$29.19
$31.98
Portata 52W:
$23.23
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
30.07 | 959.77M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
What is the risk reward ratio of investing in Collegium Pharmaceutical Inc. stockEarnings Report Alerts With Proven Results - jammulinksnews.com
What are the technical indicators suggesting about Collegium Pharmaceutical Inc.Expert Picks Watchlist For 2025 - jammulinksnews.com
When is Collegium Pharmaceutical Inc. stock expected to show significant growthValue Investing Picks For Every Investor - jammulinksnews.com
Back to School advice to help kids with ADHD Thrive| Talk of Alabama | 8.1.2025 - WBMA
What institutional investors are buying Collegium Pharmaceutical Inc. stockMarket Forecast Data Feed For Fast Growth - jammulinksnews.com
Collegium Pharmaceutical Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - 富途牛牛
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards? - Yahoo Finance
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) P/E Still Appears To Be Reasonable - simplywall.st
Institutional Tools Highlight Unusual Flow in Collegium Pharmaceutical Inc.Trade Ready Stock Watch for Short Term Published - metal.it
Real time social sentiment graph for Collegium Pharmaceutical Inc.Stock Market Watch with Smart Filters - Newser
Published on: 2025-07-29 16:28:51 - Newser
Collegium Pharmaceutical - WBFF
Identifying reversal signals in Collegium Pharmaceutical Inc.Predictive AI Engine for Smart Investing - Newser
Is Collegium Pharmaceutical Inc. stock overvalued or undervaluedStock Strategy Tracker With High Returns - jammulinksnews.com
What are the latest earnings results for Collegium Pharmaceutical Inc.Expert Picks Signals To Watch Now - jammulinksnews.com
Multi asset correlation models including Collegium Pharmaceutical Inc.Stock Entry Points Based on Technicals - Newser
Can Collegium Pharmaceutical Inc. recover in the next quarterPredictive Model for Intraday Swing Forecast - Newser
What data driven models say about Collegium Pharmaceutical Inc.’s futureAlpha Trade Flow With Risk Calibration - Newser
3 Reasons to Avoid COLL and 1 Stock to Buy Instead - Yahoo Finance
How many analysts rate Collegium Pharmaceutical Inc. as a “Buy”Turbocharged investment results - jammulinksnews.com
Why is Collegium Pharmaceutical Inc. stock attracting strong analyst attentionGet timely market insights for better trades - jammulinksnews.com
Should I hold or sell Collegium Pharmaceutical Inc. stock in 2025Invest confidently with data-driven strategies - jammulinksnews.com
What makes Collegium Pharmaceutical Inc. stock price move sharplyTremendous financial leverage - jammulinksnews.com
Published on: 2025-07-28 05:52:28 - jammulinksnews.com
Does Collegium Pharmaceutical Inc. stock perform well during market downturnsAchieve remarkable returns with smart investing - jammulinksnews.com
How Resilient Is Collegium Pharmaceutical Inc. Stock During Economic DownturnsFree Professional Portfolio Management - Newser
What risks could impact Collegium Pharmaceutical Inc. stock performanceFree Insider Trading Tips - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityFree Stock Selection - Newser
How high can Collegium Pharmaceutical Inc. stock price go in 2025Breakneck growth rates - jammulinksnews.com
Is Collegium Pharmaceutical Inc. a good long term investmentOutstanding capital appreciation - PrintWeekIndia
Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High? - Yahoo Finance
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance
What drives Collegium Pharmaceutical Inc. stock priceMarket-leading profit generation - PrintWeekIndia
Will Collegium Pharmaceutical Inc. stock benefit from AI tech trendsOutstanding growth strategies - jammulinksnews.com
Will Collegium Pharmaceutical Inc. stock split in the near futureFree Predictions - jammulinksnews.com
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
Collegium Pharmaceutical, Inc. Announces Q2 2025 Financial Results Release and Conference Call Details - Nasdaq
Press Release: Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - 富途牛牛
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Bank of New York Mellon Corp Sells 10,426 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp - Defense World
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):